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Substandard, spurious, falsely labeled, falsified,
and counterfeit (SSFFC) medications are a major
concern in countries around the world, especially
in the developing world. Forged and substandard
medications pose major threats to the well-being
and economic status of citizens in developing
countries. This research focuses on designing an
educational module and laboratory exercise that
will teach students how to detect SSFFC medications with a universal method using high-performance liquid chromatography (HPLC). This
research is also focused on the implementation of
the module at the Kilimanjaro School of Pharmacy (KSP) located in Tanzania. Acetaminophen
tablets from four countries were purchased in
Tanzania and tested at Purdue University and
KSP yielding an adequate sample of HPLC
data to establish the purity of the drug product.
Utilizing the approach developed here, additional
medications can be analyzed to combat concerns about SSFFC medications in Tanzania and
throughout the developing world. Furthermore,
we describe the implementation of this method in
Tanzania at KSP.
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Abstract

INTRODUCTION
Substandard, spurious, falsely labeled, falsified,
and counterfeit (SSFFC) medications are a global
problem with their prevalence being more apparent
in countries in the developing world including
Tanzania. SSFFC drugs pose major problems to the
individuals who take them including the emergence
of antimicrobial resistance and increased morbidity
and mortality (Mwambete, 2014). In addition,
overuse and misuse of antibiotic drugs is frequently
reported (Viberg, Kalala, Mujinja, Tomson, &
Lundborg, 2010). It is common for SSFFC drugs
to be sold by vendors in markets throughout
Tanzania. These drugs mimic the size, shape, and
9

packaging of genuine drugs without offering the
desired efficacious effect. These SSFFC drugs waste
resources, put individuals at risk of continued illness,
and discourage individuals from purchasing genuine
and life-saving drugs.
In 2008, the World Health Organization (WHO),
United Nations Educational, Scientific and Cultural Organization (UNESCO), and the International
Pharmaceutical Federation (FIP) collaborated to
create a Pharmacy Education Taskforce (PFT) in
order to develop a Pharmacy Education Action Plan
for 2008–2010. As of 2008, the WHO estimated
that there was a shortage of more than four million
healthcare workers worldwide; it was reported, as
well, that 57 countries fell under the WHO threshold
of 2.5 health care professionals per 1,000 population.
These shortages can hinder other health programs
and can form a barrier when trying to reach the
Millennium Development Goals being set to improve the quality of life for people around the globe
(Anderson et al., 2008). Pharmacists are usually not
the first healthcare professionals considered when
looking at countries with insufficient health care
systems, however, pharmacists are a vital component
of the health-care system. For many underprivileged
communities, the pharmacist is the most common
and, in some cases, the sole provider of healthcare for
several reasons, including proximity, cost associated
with visiting a doctor or physician, and lack of availability of other options (Anderson et al., 2008). In
most nonurban communities, private drugstores that
are licensed to sell over-the-counter drugs are the
prominent source of medications for poorer citizens;
the Tanzanian Ministry of Health acknowledges the
importance of private drugstores throughout Tanzania, as well, in providing health care to the country’s
citizens (Viberg et al., 2010). In addition, in Africa
over 75% of antibiotics are incorrectly prescribed
to patients (Mwambete, 2014, p. 98). This is due to
the incorrect drug type being prescribed and the
frequency of SSFFC drugs in health-care systems in
Africa (Mwambete, 2014). Having a lack of educated
pharmacists in Tanzania is an issue that needs to be
addressed in order to help provide better health care
to the people of Tanzania. To address this issue, there
needs to be a system in place to educate more pharmacists for the workforce.
This paper describes an educational module designed
to educate students about SSFFC medicines and a
laboratory exercise that illustrates the strategy for
detecting SSFFC medicines. Indirectly, this module
and laboratory exercise illustrates how drug quality
can be ensured using laboratory assays and methods.
Additionally, this paper describes a universal method
10
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for distinguishing between SSFFC and non-SSFFC
drugs. Additionally, we describe implementation of
this method in Tanzania at the Kilimanjaro School of
Pharmacy (KSP). Strategies to increase pharmaceutical education and expertise in Tanzania and ways of
detecting the sale of SSFFC drugs in the Kilimanjaro
region of Tanzania also are discussed. Alternatively,
this module also could be used outside the developing
world to illustrate the principles of high-performance
liquid chromatography (HPLC) and drug quality.
Since the Pharmacy Education Action Plan described
that a “one size fits all” educational model is not
a practical solution for providing pharmaceutical
education to all areas of the world and because some
individuals lack sufficient knowledge in certain
pharmaceutical practices (Anderson et al., 2008), the
Global Development Team of Purdue University developed a local pharmaceutical education model that
will help train the future pharmacists of Tanzania.
This module contains an initial video on the problems
of counterfeiting, a video on the utilization of HPLC to
detect SSFFC medications, and a laboratory module
utilizing the universal method to detect SSFFC drugs.
We believe these modules can be further used in the
United States to educate pharmacists.

METHODS
An Agilent 1100 HPLC equipped with ChemStation
software was used for the study. Standard HPLC
solvents were used. In Tanzania, HPLC solvents
can be obtained from Kenya and other major HPLC
suppliers. Proper laboratory personal protective
equipment (PPE) is required, including gloves,
long pants, closed toed shoes, safety glasses, and
lab coats. All glassware is cleaned and prewashed
with methanol.
An Agilent Zorbax 4.6 cm C-18 column with
5-micron particle size is used. The column is
pre-equilibrated with 50:50 ACN (Acetonitrile):
H 2O (water).
Agilent ChemStation software is used to analyze the
data. The Data Analysis tab allows easy determination of peak areas and percentages.
Typically, an average of three injections are used
for determination of percentages. In some cases,
three separate preparations with three injections
each are used.
As an example, for acetaminophen, the contents of
ten 500 mg tablets are added to a 200 milliliter (mL)
volumetric flask and diluted with 200 mL of buffer.

The solution is stirred, filtered, and tested in a
3:1 methanol to water gradient over 10 minutes.
The wavelength of the detector is set a 243 nanometers (nm).

Parameters

Values

Column

Agilent Zorbax SB-C18
4.6mmx250mm 1

Pump A

Methanol

An autonomous laboratory model using acetaminophen as the testing material, below, can provide an
understanding of the applicability of this process
to both the analysis of a medication for SSFFC
properties and the use of HPLC units by students to
understand the quality of a drug.

Pump B

Water

Mobile Phase

50 mL Methanol + 150 mL
Water

Gradient

Time (min)
0
10

The procedure outlined below constitutes our current
universal method. Furthermore, the universal method
was applied to Amoxicillin, Quinine, Coartem,
Hydrochlorothiazide and Mefloquine tablets. Our
preliminary studies suggest it can be used for these
drug products. Initial studies of Ciprofloxacin,
Dexamethasone, Metformin, Carvedilol, Amitriptyline and Haloperidol based on overlap between the
Walmart $4 list and the WHO Essential Medicines
list have been conducted.

Injection Volume

10 µL

Temperature

25°C

UV Detector

243 nm (Reference 360 nm
& 100 nm)

USP Compound

0.01 mg/ml of acetaminophen in mobile phase

EDUCATIONAL MODULE 1: ACETAMINOPHEN
Purpose

Extraction Procedure
and Drug Preparation

The United States Pharmacopeia (USP) is responsible
for setting and publishing the standards for testing the
quality of all medications. The USP contains verified
methods for analyzing drugs, including the quantified
best HPLC procedures for Acetaminophen.
In this lab, we will separate and quantify the amount
of acetaminophen in various products. Parameters
set forth in Table 1 will be utilized.

Preparation of Standard Solutions
First, 100 mg of acetaminophen was placed in a 200
mL volumetric flask. Then, 100 mL of mobile phase
was added to the flask and it was stirred and diluted
to a volume of approximately 200 mL with mobile
phase. Using a funnel and an empty flask, the solution was passed through filter paper. Finally, 1.5 mL
of solution was placed into an HPLC vial.

Solvents
The universal method makes use of four solvents:
water, methanol, acetonitrile, and 0.5M potassium

B%
75
75

•100mg of acetaminophen
in a 200mL volumetric
flask
• Add 100mL mobile
phase, stir, dilute to
volume (~200 mL mobile
phase)
• Using a funnel and an
empty flask, pass solution through filter paper
• Extract 1.5mL of this
solution into an HPLC
test tube

Stability Information

The prepared drug buffer
has been shown to remain
stable for up to 2 weeks
under refrigeration

Acceptance Criteria

No peaks on the blank

Acceptance Results

>99% peak area within 5 to
5.1 minutes

Average Retention
Time

5.05 minutes

Average Area %

99.95%

1

USP suggests 3.9mm x 30 cm, L1 packing
Table 1. HPLC method for acetaminophen.

phosphate. For acetaminophen, only methanol and
water were utilized.

Preparation of Drug Tablet Assay Samples
Tablet extraction was completed for Equate brand
500 mg acetaminophen tablets from Tanzania. This
was prepared by crushing ten Equate brand 500 mg
acetaminophen tablets with a mortar and pestle,
11
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We also utilized acetaminophen USP-level standard
from Purdue University Industrial and Physical
Pharmacy Department and Methanol purchased from
Sigma-Aldrich. Fresh ultrapure water was obtained
from a Milli-Q Integral system.

A%
25
25

adding 100 mg of the crushed powder to a 200 mL
volumetric flask, and adding 100 mL of mobile
phase to the flask. After approximately 10 minutes
of mixing, the solution is diluted to 200 mL with
mobile phase and mixed for approximately another
5 minutes. Using a funnel and an empty flask, the
solution is passed through filter paper. Finally, 1.5
mL of solution is placed in an HPLC vial.

Measurements
Each HPLC trial, for all samples, consisted of a
blank run and 3 sample runs. A reference standard
was prepared and tested in three separate trials. The
average retention time of the reference standard was
5.04 minutes with an average peak area of 99.95%. A
sample result is shown in Figure 1.

Figure 2. Sample chromatogram for HPLC
acetaminophen tablet extraction is indicative
of expected results for this procedure.

Figure 1. Sample chromatogram for HPLC
acetaminophen reference standard.

Three separate extractions of Equate brand
acetaminophen tablets were prepared and tested in
three separate trials each, for a total of nine trials.
The average results of these extractions were used to
set acceptance limits for this method as a retention
time of 5.05 minutes and a peak area percent of
99.95% with a standard deviation of 0.011 and 0.053,
respectively. Limits to the acceptance criteria were
set based on verification that extraction test results
were significantly tighter than these values. A sample
result for the extractions, indicative of expected
results for this method is shown in Figure 2.
One unfiltered extraction of Equate brand
acetaminophen tablets was prepared and tested in
12
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Figure 3. HPLC chromatogram for unfiltered
acetaminophen tablet extraction.

three separate trials. Tablet samples were filtered
for accurate results. If the sample was not filtered, it
may appear similar to Figure 3, with two wide peaks
between 4.5 and 5.5 minutes.
Once the universal method for acetaminophen was
established, further studies were conducted on
amoxicillin tablets using the HPLC.

EDUCATIONAL MODULE 2: AMOXICILLIN
Purpose
Established United States Pharmacopeia (USP) methods were referenced when shaping the proper HPLC
method for amoxicillin capsules. These reference
methods are governed by the USP who is responsible
for the determining and publication of analysis on the
quality of all medications.
Amoxicillin will be isolated and measured, and
results will be compared to products of the generic
tablet of the same makeup in this laboratory module.
Supplies for the module were obtained from Purdue University Industrial and Physical Pharmacy
Department (amoxicillin USP-level), Sigma-Aldrich
(methanol), and Milli-Q Integral System (fresh ultrapure water).

Preparation of Standards
First, 250 mg of amoxicillin was measured and
placed in a 100 mL volumetric flask. The flask with
its contents was then diluted with 100 mL of potassi
um phosphate buffer at pH 5 (Pump A). This mixture was then stirred for approximately 30 minutes.
Utilizing a funnel and an empty flask, the contents
of the volumetric flask were strained through filter
paper, and 1.5 mL of this sieved solution was placed
in an HPLC vial for analysis.

Solvents
Four solvents are essential in the universal method:
water, methanol, acetonitrile, and 0.5 M potassium
phosphate. For amoxicillin, only methanol and potassium phosphate were utilized.

A single capsule of amoxicillin is fragmented,
and the contents are then placed into a 100 mL
volumetric flask. Amoxicillin was diluted with
100 mL of buffer from Pump A. This blend is
mixed for approximately 30 minutes. Utilizing
a funnel and an empty flask, the contents of the
volumetric flask were strained through filter paper
and 1.5 mL of this sifted solution was placed in an
HPLC vial for analysis.

Measurements
For all samples and their HPLC trials, a blank run
and three sample runs were implemented. In three
separate trials, a reference standard was prepared

In total, nine trials of amoxicillin capsules were
assessed. It was found that the accepted limits for
the amoxicillin method were set at a retention time
of 5.76 and a peak area of 94.12% with a standard
deviation of 0.071 and 1.47, respectively.

DISCUSSION
HPLC analysis was utilized as opposed to other
methods in this project for several reasons. HPLC
excels at the analysis of small, organic molecules
which is a feature shared by every drug analyzed
or every drug intended to be analyzed. For this
reason, HPLC has also been widely utilized by the
pharmaceutical industry and is the main method
used to analyze drugs for purity. Additionally,
HPLC is highly adaptable. Many different variables
can be manipulated on an HPLC, including the size
and type of column, polarity of the solvents, flow
rate, wavelength of excitation, injection size, and
several others. This makes HPLC very versatile,
able to be manipulated to analyze an endless
numbers of drugs, and perfect for the development
of a universal method.
Separations using high-pressure liquid
chromatography (HPLC) depend upon the basic
processes of adsorption, partition, ion exchange,
and molecular exclusion, as previously discussed.
The advantages of using HPLC as compared to
classical chromatographic methods are greater
speed, precision, accuracy, and ease of operation.
The column materials used in HPLC are of unique
structure and provide the basis for separations.
A wide variety of aqueous and nonaqueous solvents
may be used as the mobile phase. Solvents must be
degassed before they can be used or the detector
will adsorb bubbles and erroneous readings will be
obtained. The mobile phase is generally pumped
through the column under pressure. Most commercial instruments are capable of providing pressures
up to 7000 psi.
Ultraviolet (UV) absorbance and refractive index
detectors are most frequently used in HPLC. UV
detectors are available with fixed and variable
wavelengths. This type of detector monitors the
column effluent continuously as it passes through the
microcell. Since the signal is measured in absorbance
units and recorded versus time, a differential plot
(peak) is obtained on the recorder.
13
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Preparation of Drug Tablet Assay Samples

and used as a comparison. The reference standard’s
average retention time for amoxicillin was 5.76
minutes with an average peak area of 94.12%.

Drug Name

Pump A

Pump B

Injection
Temperature
Volume

UV Detector

Acetaminophen

Methanol

Water

10 µL

25 °C

243 nm

Amitriptyline

Methanol

1.42g/L Potassium
Phosphate Adjusted
with Diluted
Phosphoric Acid

20 µL

45 °C

215 nm

Amoxicillin (Amoxicillin
Capsules, Diomax 250)

Buffer pH=5 Potassium Phosphate
(2.72g/L)

Methanol

10 µL

40 °C

210 nm

Ciprofloxacin

Acetonitrile

Phosphoric Acid

10 µL

29-31 °C

278 nm

Haloperidol

Methanol

Potassium Phosphate 15 µL

25 °C

254 nm

Hydrochlorothiazide

Acetonitrile

0.05M Potassium
Phosphate (pH=3.0)

20 µL

37 °C

272 nm

Loratadine

Acetonitrile

Methanol

15 µL

25-35 °C

254 nm

Lumefantrine/ Artemether
(Lumartem)

0.05M Potassium
Phosphate (pH=3.0)

Acetonitrile

20 µL

25 °C

303 nm

Mefloquine (Mephaquin)

0.05M Potassium
Phosphate

Methanol

20 µL

30 °C

283 nm

Acetonitrile

10 µL

30 °C

347 nm

Quinine (Quinine Sulphate 0.05M Potassium
BP)
Phosphate (pH=2.0)
Table 2. Drugs with their best solvent system.

The USP contains a general chapter, USP<621>,
on chromatography. This chapter describes
approaches to separations and analysis of drugs
using chromatographic methods. It also describes
quantitative analysis of drugs using both external
standard and internal standard. The USP sells
standards for this purpose. The availability of
standards makes this study much more feasible.
When first beginning the project, many important
decisions, including which drugs to test and how to
adapt our methods for universal drug applicability,
had to be made. The initial criterion was choosing drugs that were the low-hanging fruit: cheap,
readily accessible, widely utilized, and simple to
test. Amoxicillin was an all but obvious first choice
based on these criteria. After this selection, drugs
that seemed like they were widely utilized or might
be readily utilized throughout Africa were chosen.
These criteria led to hydrochlorothiazide, quinine,
mefloquine, lumefantrine, and artemether. For
future studies, we have cross-referenced the WHO’s
essential medicines list with the Wal-Mart $4 drug
list. This provided a list of drugs that we know will
be medically necessary and affordable in these areas,
including acetaminophen, loratadine, ciprofloxacin,
dexamethasone, metformin, carvedilol, amitriptyline
and haloperidol.
14
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These drugs, just like any other set of drugs, vary
greatly in terms of solubility. Some are more polar
and, therefore, readily soluble in our polar solvents,
while others are more nonpolar. Thus, these different
drugs have different solubility and different rates of
dissolution. That being said, the solubility of these
drugs is similar enough that we have been able to
both dissolve them all in the same solvents and utilize the same column for analysis.
Upon starting this project, one of the major
challenges was proving that the results were
consistent with what was, in fact, correct. To do this,
USP standards were purchased, and the results were
compared to those displayed from the USP analysis
in the monograph for each drug. If this method
produced results comparable to the USP HPLC
results, it was concluded that method was suitable
for that specific drug.
The thought process for choosing the original drugs
has been previously discussed. This process directly
influenced the process for selecting the solvents.
The only solvents utilized in the acetaminophen
method were readily accessible and widely used.
After selecting other drugs to test and researching
methods by which to analyze them, it was found that
four solvents were common to HPLC methods per

Sample Number (Date
Tested)

Retention Time (min)

Area (mAu*s)

Area %

Sample 1 (Jan. 26)

5.050666667

20052.46667

100

Sample 1 (Jan. 27)

5.067333333

16096.4

100

Sample 2 (Feb. 1)

5.042333333

16200.4

99.93713333

Sample 2 (Feb. 3)

5.06

16241.45

100

Sample 3 (Feb. 1)

4.929

104301.5

99.22085

Sample 4 (Feb. 3)

5.0505

16237.15

100

Sample 4 (Feb. 8)

5.096

16221.63333

99.79413333

Table 3. Retention time studies performed by students at Purdue.

AUC
Standard No.

Replicate 1

Replicate 2

Replicate 3

Average

Std. Dev.

RSD

1

18604.1

18943.1

19004

18850.4

215.464545

1.14302373

2

9512.9

9504.3

9445.4

9487.53333

36.7410307

0.38725588

3

1848.7

1856.2

1853.8

1852.9

3.8301436

0.20671076

AVERAGE =

0.57899679

Table 4. Example precision data obtained from the Kilimanjaro School of Pharmacy.

the USP. This proved to us that they would be able to
be manipulated to analyze many different drugs and,
therefore, suitable for our universal method.

RESULTS
Results of Studies Performed by
Students at Purdue University
Investigations at Purdue University focused on
determining which combinations of the four solvents
worked best for the universal method. Table 2 shows
all drugs tested and the best solvent system associated with each one.

The Purdue team found an average retention time
over four experiments of 5.05 minutes +/-0.01. Area
and area percent of the primary peak is reported
for each experiment in Table 3. It should be noted
that Samples 3 and 6 were not properly filtered prior
to analysis.
The results in Table 3 indicate that the developed
method tested by Purdue students was repeatable
and able to verify purity within 99% peak area.

Results of Studies Performed by Students
at the Kilimanjaro School of Pharmacy
In March of 2016, in our manufacturing course in
Purdue’s master’s program at the Kilimanjaro School
of Pharmacy, a variety of procedures were performed
to help students better understand the use of HPLC.
These procedures included typical validation procedures like linearity, precision, and accuracy and tablet
assaying to compare the quality of different tablets.
15
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In an effort to make testing as simple as possible, it
was decided to use four solvents. This is a challenge
as the chemistry of each drug is different, and they
each have HPLC procedures previously developed
to optimize their elution through the instrument
that may or may not involve the solvents that were
chosen. All of our methods are based on the four
solvents: water, methanol, acetonitrile, and 0.5M
potassium phosphate at varied pH levels using phosphoric acid for all pH adjustments. These methods
are being called our universal methods, and we have
worked to find the right settings, which will have
a single peak for each of the initial five common
SSFFC drugs of interest.

As an example, acetaminophen tablets were tested
using the method at both Purdue and at KSP. Purdue
students tested four tablets obtained from a local
pharmacy and manufactured in the US. Eight KSP
students each tested three tablets manufactured in
Tanzania, China or India.

Expected/Real
Concentration (mg/mL)

AUC

Calculated
Concentration (mg/mL)

% RECOVERY

0.63

18604.1

0.561023

89.05126984

0.315

9512.9

0.288287

91.51968254

0.126

3544

0.109220

86.68253968

AVERAGE =

89.08449735

Table 5. Example accuracy data obtained from the Kilimanjaro School of Pharmacy.

Country of Origin

AUC

Calculated Concentration
(mg/mL)

Mass Content of
Acetaminophen (mg)

China

15093.4

0.455702

455.702

Tanzania

15723.1

0.474593

474.593

India

15196.1

0.458783

458.783

Table 6. Example tablet assay data obtained from the Kilimanjaro School of Pharmacy.

the preparation of multiple standard solutions. From
these standard solutions, multiple AUC measurements were made and recorded. From this data,
the relative standard deviation was measured and
averaged across the data. An example of this data is
provided in Table 4.

Figure 4. Example calibration curve obtained from the
Kilimanjaro School of Pharmacy.

The study involved carrying out a linearity, precision, and accuracy analysis utilizing a secondary
reference standard. For linearity, a proportional
relationship between response and concentration is
demonstrated for a desired range of concentrations.
A serial dilution method was used from a stock
solution of acetaminophen in mobile phase. From
this serial dilution, the area under the curve (AUC)
was measured and plotted against the respective
concentration. These data were used to construct a
calibration curve, as shown in Figure 4.
For precision, the relative repeatability of the analytical method is measured. This was done through
16
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For the accuracy measurements, the relative
closeness of the results of the analytical method to
the true value is measured. This was done through
the preparation of several concentrations through
serial dilution. The AUC was then measured and
used to estimate the concentration with the prepared
calibration curve. Finally, using the estimated
concentration, the percent recovery was estimated
compared to the expected concentration and averaged
across the data. An example of this data is provided
in Table 5.
Finally, a tablet assay was used to illustrate how
HPLC can be used to compare the content and
quality of acetaminophen tablets produced in different countries. Tablets produced in China, Tanzania,
and India were studied. The AUC was measured and
the concentration was estimated using a previously
prepared calibration curve. Using the known volume
of the mobile phase used in the preparation of the
sample solutions, the mass content of the tablets was
determined from the estimated concentration. An
example of this data is provided in Table 6. Tablets
from all three countries were slightly below label but
still within 90% of the labeled amount.

CONCLUSION
The discrepancies in the results between the two
groups of students highlight a need for clarity. This
module is most effective when a calibration curve is
developed and drug concentrations are analyzed for
percent recovery in addition to observation of the
retention time and peak area percentage. Retention
time verifies the correct compound is in the drug
product, and the percent recovery allows for method
verification as well as quality metrics. Peak area percentage can be used to understand the level of purity
in the drug.
The results obtained by both the student teams at
Purdue University and Kilimanjaro School of
Pharmacy indicate that the concept of a universal
method is a useful tool for addressing testing of
SSFFC drugs. The developed method was validated
and conforms to a broader attempt by students at
both institutions to create HPLC methods that are
simple and effective at quantifying the active pharmaceutical ingredient in an oral formulation.

NOTE
The Sustainable Medicine Program in Tanzania was
established by Stephen Byrn (Purdue University
College of Pharmacy), Sister Zita Ekeocha and John
Chilunda (St. Luke Foundation/Kilimanjaro School
of Pharmacy), and Joseph Fortunak (Howard University). The program was developed to help combat
poor quality of medications due to counterfeiting
and manufacturing issues. The program consists of
educational programs in pharmaceutical sciences
and good manufacturing practices (GMP), and a
GMP pharmaceutical manufacturing facility and
analytical laboratory at St. Luke Foundation/Kili-

manjaro School of Pharmacy. Since its inception in
2007, this certificate program serves as a transition
to a Master of Science in technology, leadership, and
innovation with a concentration in biotechnology,
innovation, and regulatory affairs (BIRS) through
the Purdue Polytechnic Institute and its Center for
Professional Studies.
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